Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Catalyst Pharmaceuticals - 19 Year Stock Price History | CPRX

Historical daily share price chart and data for Catalyst Pharmaceuticals since 2006 adjusted for splits and dividends. The latest closing stock price for Catalyst Pharmaceuticals as of May 09, 2025 is 23.37.
  • The all-time high Catalyst Pharmaceuticals stock closing price was 25.74 on March 24, 2025.
  • The Catalyst Pharmaceuticals 52-week high stock price is 26.16, which is 11.9% above the current share price.
  • The Catalyst Pharmaceuticals 52-week low stock price is 14.75, which is 36.9% below the current share price.
  • The average Catalyst Pharmaceuticals stock price for the last 52 weeks is 20.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Catalyst Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 22.7220 21.5200 25.7400 19.5300 23.3700 11.98%
2024 17.7037 17.1100 23.9300 13.1800 20.8700 24.15%
2023 14.4758 18.0600 21.0500 11.5000 16.8100 -9.62%
2022 10.4443 6.9200 19.5000 5.3100 18.6000 174.74%
2021 5.3105 3.5300 7.4500 3.4500 6.7700 102.69%
2020 3.9635 3.7700 5.2100 2.6100 3.3400 -10.93%
2019 4.3321 2.1100 7.4300 2.1100 3.7500 95.31%
2018 3.0861 4.0100 4.0100 1.9200 1.9200 -50.90%
2017 2.3563 1.1300 4.4000 1.0900 3.9100 272.38%
2016 1.0943 2.3200 2.3600 0.5551 1.0500 -57.14%
2015 3.6925 2.9400 5.7400 2.3300 2.4500 -17.51%
2014 2.4007 2.1500 3.4200 1.7300 2.9700 52.31%
2013 1.2638 0.4430 3.3900 0.4300 1.9500 348.28%
2012 1.0501 1.3000 1.9900 0.3930 0.4350 -66.28%
2011 1.2816 1.1300 1.9300 0.9600 1.2900 30.30%
2010 1.0181 0.6100 2.0000 0.5550 0.9900 57.14%
2009 1.1935 2.2500 2.7500 0.4099 0.6300 -65.00%
2008 3.1467 3.4600 4.4400 1.3400 1.8000 -47.83%
2007 3.7359 4.5000 6.8300 2.5000 3.4500 -28.57%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.776B $0.492B
Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights to Firdapse (for treating LEMS) from BioMarin Pharmaceutical Inc. for its development and commercialization in the U.S. Firdapse is currently approved in the European Union and in the U.S. for treating of LEMS in adults. The company also plans to file a supplemental new drug application for Firdapse to treat pediatric patients with LEMS.?The company is also strengthening the commercial portfolio of Firdapse. It has already received multiple patents that cover the treatment of all amifampridine metabolizer types within the LEMS patient population.?Apart from Firdapse, the company is working on a generic version of Lundbeck's Sabril, CPP-109, for the treatment of infantile spasms and complex partial seizures.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.222B 35.35
Zoetis (ZTS) United States $71.986B 26.86
Daiichi Sankyo, - (DSNKY) Japan $47.632B 24.23
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $19.756B 0.00
Summit Therapeutics (SMMT) United States $18.307B 0.00
Merck (MKKGY) Germany $17.693B 14.64
United Therapeutics (UTHR) United States $13.893B 12.29
Shionogi (SGIOY) Japan $13.832B 13.86
Neurocrine Biosciences (NBIX) United States $11.630B 39.84
IPSEN (IPSEY) France $9.997B 0.00
Orion OYJ (ORINY) Finland $8.541B 23.10
Corcept Therapeutics (CORT) United States $7.569B 61.53
Stevanato Group S.p.A (STVN) Italy $6.808B 41.63
Madrigal Pharmaceuticals (MDGL) United States $6.651B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.212B 0.00
Grifols, S.A (GRFS) Spain $5.019B 0.00
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.062B 0.00
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.312B 12.64
NewAmsterdam Pharma (NAMS) Netherlands $2.116B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.765B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.650B 0.00
Guardian Pharmacy Services (GRDN) United States $1.613B 0.00
Indivior (INDV) United States $1.514B 6.42
Evotec AG (EVO) Germany $1.388B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Dyne Therapeutics (DYN) United States $1.283B 0.00
Ocular Therapeutix (OCUL) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Enliven Therapeutics (ELVN) United States $0.914B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Collegium Pharmaceutical (COLL) United States $0.876B 4.73
Ardelyx (ARDX) United States $0.871B 0.00
Harrow (HROW) United States $0.865B 0.00
Xeris Biopharma Holdings (XERS) United States $0.807B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.686B 0.00
AleAnna (ANNA) United States $0.679B 0.00
Organogenesis (ORGO) United States $0.677B 0.00
Xencor (XNCR) United States $0.625B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
Bioventus (BVS) United States $0.557B 14.17
Savara (SVRA) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.543B 11.81
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.495B 0.00
Elite Pharmaceuticals (ELTP) United States $0.466B 0.00
Altimmune (ALT) United States $0.447B 0.00
Zevra Therapeutics (ZVRA) United States $0.426B 0.00
CytoDyn (CYDY) United States $0.417B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.404B 0.00
Verve Therapeutics (VERV) United States $0.399B 0.00
Siga Technologies (SIGA) United States $0.389B 8.12
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Heron Therapeutics (HRTX) United States $0.331B 0.00
Aquestive Therapeutics (AQST) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.27
Avita Medical (RCEL) United States $0.247B 0.00
Wellgistics Health (WGRX) United States $0.216B 0.00
ProKidney (PROK) United States $0.205B 0.00
OmniAb (OABI) United States $0.192B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Esperion Therapeutics (ESPR) United States $0.177B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Nanobiotix S.A (NBTX) France $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.156B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.145B 0.00
Larimar Therapeutics (LRMR) United States $0.143B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Lyell Immunopharma (LYEL) United States $0.126B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.113B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Lexeo Therapeutics (LXEO) United States $0.100B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Cassava Sciences (SAVA) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Corbus Pharmaceuticals Holdings (CRBP) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 50.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Surrozen (SRZN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00